skip to Main Content

IRBM contribution to Frontiers in Neuroscience

In an original research publication for the current issue of Frontiers in Neuroscience, IRBM and collaborators developed and applied novel ultrasensitive immunoassays to enable detection of synuclein and S129 phosphorylated synuclein in clinical samples. The new research demonstrated that S129…

New IRBM contribution to Metabolites

As part of a special issue on exercise metabonomics, IRBM recently published a paper in Metabolites exploring the limits and advantages of using saliva to observe metabolic responses to physical exercise. Saliva offers a number of advantages over traditional blood…

IRBM Contribution To Molecular Pharmaceutics

IRBM contribution to Molecular Pharmaceutics

Earlier this year, we published a paper in Molecular Pharmaceutics that highlights our work with the CHDI Foundation to develop therapeutics that substantially improve the lives of those affected by Huntington’s disease. It is essential to understand the physiochemical properties…

Back To Top